This study assesses the feasibility of SGM-101, a fluorochrome-labeled anti-carcinoembryonic
antigen monoclonal antibody, for intraoperative near-infrared fluorescence imaging of
colorectal brain metastases by injecting SGM-101 intravenously 3 - 5 days prior to surgery.